There was a significant reduction in CRP (difference between groups = −23.9%, 95% CI −46.3 to −1.4, p = 0.038) and IL-6 (difference between groups = −37.7%, 95% CI −57.6 to −17.7, p < 0.001) percentage post treatment with a-taVNS, after adjusting for unbalanced variables at baseline (vaccination status, anxiety score, sex, and body mass index) (Figure 2). The gene discussed is IL6; the disease is Anxiety.